Rituximab

Related by string. rituximab * * refractory rituximab naive . rituximab refractory follicular . Rituxan rituximab . rituximab Rituxan . MabThera rituximab . rituximab Rituxan R . rituximab Rituxan ® . rituximab monotherapy . rituximab refractory . monoclonal antibody rituximab . rituximab infusion . R Rituximab Herceptin . rituximab infusions . rituximab monoclonal antibody *

Related by context. All words. (Click for frequent words.) 76 Bevacizumab 73 Erlotinib 73 Trastuzumab 72 Bortezomib 72 Gemcitabine 72 Herceptin trastuzumab 72 Irinotecan 71 Fludarabine 71 Dasatinib 71 biologic therapy 70 rituximab 70 Adalimumab 70 Etanercept 70 Epratuzumab 70 Sorafenib 69 Tarceva erlotinib 69 Docetaxel 69 Ofatumumab 69 Natalizumab 69 Imatinib 69 Lenalidomide 69 Capecitabine 69 Oxaliplatin 69 Pemetrexed 69 Dapagliflozin 69 Infliximab 69 bevacizumab Avastin ® 69 Exemestane 69 Abatacept 69 Boceprevir 68 Amrubicin 68 CHOP chemotherapy 68 Alemtuzumab 68 bevacizumab Avastin 68 Pertuzumab 68 thalidomide Thalomid 68 Vandetanib 68 Azacitidine 68 Camptosar ® 68 Pfizer Sutent 68 Mitoxantrone 67 ixabepilone 67 Taxotere ® 67 Pixantrone 67 Traficet EN 67 infliximab Remicade 67 Gleevec resistant 67 mycophenolate mofetil 67 adalimumab Humira 67 Cetuximab 67 Nilotinib 67 Decitabine 67 Rituxan rituximab 67 Everolimus 67 Tocilizumab 67 Bosutinib 67 Cyclophosphamide 67 GW# [003] 67 rituximab Rituxan 67 Ustekinumab 67 dasatinib Sprycel ® 67 tyrosine kinase inhibitor 67 Cyclosporine 67 Melphalan 67 Follicular Lymphoma 67 erlotinib Tarceva ® 67 Daclizumab 67 Torisel 66 pegylated liposomal doxorubicin 66 Pioglitazone 66 Tacrolimus 66 Nexavar ® 66 Fludara 66 anakinra 66 Treanda 66 Rituxan 66 Gleevec imatinib mesylate 66 HuMax CD4 66 Carboplatin 66 pegfilgrastim 66 etanercept Enbrel 66 Pazopanib 66 Aflibercept 66 MabThera 66 Temsirolimus 66 gastrointestinal stromal tumors GIST 66 Monotherapy 66 gefitinib Iressa 66 Gefitinib 66 bendamustine 66 Hycamtin 66 Anti TNF 66 Cisplatin 66 olmesartan 66 Relapsed Refractory 66 relapsed multiple myeloma 66 azacytidine 66 TNF Tumor Necrosis Factor 66 Interferon beta 66 paclitaxel Taxol 66 MabThera Rituxan 66 sorafenib Nexavar 66 tocilizumab 66 Neoadjuvant 66 Rituxan MabThera 66 ZOLINZA 66 Pegylated Interferon 66 Golimumab 66 Fulvestrant 66 Valsartan 66 Lapatinib 66 SPRYCEL ® 65 Fluorouracil 65 trastuzumab Herceptin 65 Degarelix 65 pemetrexed 65 alefacept 65 idarubicin 65 Velcade bortezomib 65 Metastatic Colorectal Cancer 65 standard chemotherapy regimen 65 erlotinib Tarceva 65 alkylating agent 65 Genentech Rituxan 65 imatinib Gleevec 65 azacitidine 65 ACE Inhibitors 65 Radioimmunotherapy 65 lumiliximab 65 Rosiglitazone 65 Peginterferon 65 Lacosamide 65 MabCampath 65 Paraplatin ® 65 FTY# 65 PEGylated Fab fragment 65 Ranibizumab 65 PKC# 65 YONDELIS 65 Ziprasidone 65 metastatic renal cell carcinoma 65 rilonacept 65 receptor tyrosine kinase inhibitor 65 Fingolimod 65 vorinostat 65 fluorouracil 65 CD# antibody [001] 65 Epirubicin 65 CD# monoclonal antibody 65 pertuzumab 65 daclizumab 65 Neulasta ® 65 Laquinimod 65 Zarnestra 65 Azathioprine 65 adalimumab 65 nilotinib 65 Adjuvant Therapy 65 Taxotere docetaxel 65 Avastin bevacizumab 65 Noxafil 65 ZEVALIN 65 Omalizumab 65 vandetanib 65 Corticosteroids 65 calcineurin inhibitors 65 FASLODEX 65 Navelbine ® 65 Copegus ribavirin 65 relapsed refractory 65 Enzastaurin 65 xanthine oxidase inhibitor 65 cyclophosphamide doxorubicin vincristine 64 Zolinza 64 Bosentan 64 Lubiprostone 64 Cytarabine 64 Fludara ® 64 Taxol paclitaxel 64 Acute Myeloid Leukemia 64 proteasome inhibitors 64 Bendamustine 64 mTOR inhibitor 64 Pulmonary Arterial Hypertension 64 pan HDAC inhibitor 64 Hodgkin lymphoma NHL 64 lapatinib Tykerb 64 Posaconazole 64 beta 1a 64 Nexavar sorafenib 64 metastatic malignant 64 Dalbavancin 64 Kepivance 64 indolent NHL 64 Temozolomide 64 Anastrozole 64 immunosuppressant 64 mapatumumab 64 Anthracycline 64 Naive Patients 64 Revlimid lenalidomide 64 bortezomib Velcade 64 mRCC 64 Investigational Agent 64 Relapsed Refractory Aggressive 64 proteasome inhibitor 64 Luteinizing Hormone Releasing Hormone 64 cetuximab Erbitux R 64 imatinib Gleevec ® 64 antimetabolite 64 Vidaza azacitidine 64 Recombinant Human 64 amphotericin B 64 Ganciclovir 64 chemotherapeutic regimen 64 epoetin alfa 64 VAPRISOL 64 Zoledronic acid 64 Talabostat 64 cilengitide 64 Interferon beta 1a 64 Gemzar ® 64 Losartan 64 Pirfenidone 64 vidofludimus 64 Certolizumab pegol 64 Proxinium TM 64 Tiotropium 64 Interferon alfa 64 Epidermal Growth Factor Receptor 64 temsirolimus 64 Diffuse Large B 64 ibritumomab tiuxetan 64 sorafenib tablets 64 Crizotinib 64 Platinol ® 64 dacarbazine 64 humanized anti 64 Well Tolerated 64 Vaprisol 64 trabectedin 64 5 Fluorouracil 64 ORENCIA R 64 Ocrelizumab 64 Onco TCS 64 Ranolazine 64 Dabigatran 64 Eculizumab 64 DOXIL 64 TYZEKA 64 Cutaneous T 64 cetuximab 64 Glatiramer Acetate 64 Rilonacept 64 infliximab 64 immunosuppressant drug 64 Catena ® 64 Cladribine 64 tiuxetan 64 oral prodrug 64 Jevtana 64 Antitumor Activity 64 Taxol ® 64 Alkeran 64 EGFr 64 TORISEL 64 Clofarabine 64 Voreloxin 64 angiotensin II receptor blocker 63 Previously Untreated 63 Roche Actemra 63 Ixempra 63 FOLFIRI 63 follicular NHL 63 Calcitonin 63 BAY #-# 63 nucleoside analog 63 lenalidomide Revlimid R 63 Sanofi Aventis Taxotere 63 topotecan 63 Combination Therapy 63 Hycamtin ® 63 ritonavir boosted 63 romiplostim 63 efalizumab 63 Advanced Renal Cell 63 angiotensin receptor blocker ARB 63 IRESSA 63 AVASTIN 63 CIMZIA TM 63 docetaxel Taxotere ® 63 Moxifloxacin 63 Advagraf 63 chronic lymphocytic leukemia CLL 63 Clolar ® 63 sunitinib malate 63 Xanafide 63 gemcitabine Gemzar 63 Previously Treated 63 atacicept 63 Novel Oral 63 Vorinostat 63 EGFR inhibitors 63 LHRH agonist 63 Myelofibrosis 63 sodium glucose cotransporter 63 Celecoxib 63 sunitinib 63 Doxorubicin 63 azathioprine 63 Mycophenolate Mofetil 63 SUTENT 63 Aptivus ® 63 Cellcept 63 Alfimeprase 63 abatacept 63 Telbivudine 63 cinacalcet 63 decitabine 63 imatinib resistant 63 Myelodysplastic Syndrome MDS 63 Cloretazine 63 Actemra 63 TEMODAL 63 Lupus Nephritis 63 cetuximab Erbitux ® 63 uric acid lowering 63 PSMA ADC 63 Novartis Gleevec 63 Adjuvant Treatment 63 Meets Primary Endpoint 63 Phase III Trials 63 Newly Diagnosed Multiple Myeloma 63 glatiramer acetate 63 Darunavir 63 Methotrexate 63 chemotherapeutic drug 63 EndoTAG TM -1 63 boosted protease inhibitor 63 Glufosfamide 63 Leukine 63 fulvestrant 63 Ibritumomab Tiuxetan 63 adriamycin 63 vinorelbine 63 Carfilzomib 63 Hydroxyurea 63 tafamidis 63 Gleevec imatinib 63 Enzyme Replacement Therapy 63 sunitinib Sutent ® 63 Combination therapy 63 Remicade infliximab 63 Fluconazole 63 Romiplostim 63 CAELYX 63 Ribavirin 63 Fluticasone 63 HuMax EGFr 63 calcineurin inhibitor 63 Actemra tocilizumab 63 Topotecan 63 TREDAPTIVE 63 daunorubicin 63 Vidofludimus 63 bleomycin 63 PEGylated anti 63 Epivir 63 Dacogen decitabine 63 RhuDex 63 Paclitaxel 63 hA# 63 TNF inhibitor 63 Icatibant 63 herpetic keratitis 63 DFMO 63 angiogenesis inhibitor 63 Entecavir 63 cyclosporin 63 temozolomide 63 EOquin TM 63 Maraviroc 63 basiliximab 63 IV Busulfex 63 leukotriene receptor antagonist 63 Mantle Cell Lymphoma 63 TNF alpha inhibitor 63 pegylated interferon alpha 63 Tumor Necrosis Factor 63 Doxil ® 62 galiximab 62 plus DOXIL 62 Tasigna nilotinib 62 PEG interferon 62 HDAC Inhibitor 62 chlorambucil 62 visilizumab 62 Chronic Myeloid Leukemia 62 Mepact 62 alfa 2a 62 multiple myeloma MM 62 Roche Xeloda 62 Phase III Trial 62 relapsing multiple sclerosis 62 Leukine ® 62 echinocandin 62 cyclophosphamide methotrexate 62 BEXXAR 62 cabazitaxel 62 L asparaginase 62 metastatic hormone refractory 62 Zevalin 62 IAP inhibitor 62 abatacept Orencia 62 ofatumumab 62 Relapsed 62 dasatinib Sprycel 62 docetaxel chemotherapy 62 leukemia CLL 62 imatinib mesylate 62 Filgrastim 62 liposomal formulation 62 Initiate Clinical Trial 62 docetaxel Taxotere 62 Renal Cell Carcinoma 62 microtubule inhibitor 62 OHR/AVR# 62 Pharmacokinetics PK 62 Letrozole 62 TAXOTERE R 62 ACZ# 62 Arcalyst 62 Maribavir 62 adefovir dipivoxil 62 Rivaroxaban 62 pomalidomide 62 Arixtra 62 Hormone Refractory Prostate Cancer 62 Epoetin Alfa 62 Sitagliptin 62 goserelin 62 Solid Tumors 62 fludarabine 62 Immunosuppression 62 Bayer Onyx 62 Malignant Melanoma 62 canakinumab 62 Gleevec Glivec 62 dasatinib 62 Anthracyclines 62 chimeric monoclonal antibody 62 ara C 62 factor TNF 62 EGFR TKI 62 elotuzumab 62 investigational humanized monoclonal antibody 62 Mipomersen 62 posaconazole 62 ORENCIA ® 62 enzastaurin 62 Helicobacter pylori eradication 62 Rasagiline 62 MyVax R 62 Omacetaxine 62 NeoRecormon 62 tigecycline 62 Sapacitabine 62 anticancer therapy 62 Inhalation Aerosol 62 oblimersen 62 Pradefovir 62 low dose cytarabine 62 sunitinib Sutent 62 Etoposide 62 DMARD 62 Telmisartan 62 Cabazitaxel 62 factor Xa 62 ULORIC 62 leukemia AML 62 Saxagliptin 62 BRAF inhibitor 62 icatibant 62 Campath 62 interferon IFN 62 myelofibrosis polycythemia vera 62 superficial bladder cancer 62 cancer vaccine Norelin 62 LHRH antagonist 62 T#I [002] 62 GPIIb IIIa 62 Bezielle 62 REVLIMID R 62 previously untreated follicular 62 Denufosol 62 Granulocyte Colony Stimulating Factor 62 NOXAFIL 62 Doxil 62 Pegasys ® 62 terlipressin 62 omalizumab 62 LEUKINE 62 Taxotere R 62 Pralatrexate 62 ganciclovir 62 malignant ascites 62 Olmesartan 62 Eltrombopag 62 LHRH 62 JAK Inhibitor 62 Personalized Immunotherapy 62 Anti VEGF 62 alpha interferon 62 Zenapax 62 lupus nephritis 62 Pegylated 62 Targretin 62 Sutent sunitinib 62 Anti Tumor 62 APTIVUS r 62 irbesartan 62 Disease Progression 62 Ambrisentan 62 luteinizing hormone releasing 62 AQ4N 62 IAP inhibitors 62 EGFR tyrosine kinase inhibitors 62 Complicated Skin 62 Diabetic Neuropathy 62 Aliskiren 62 TYKERB 62 Cetrorelix 62 estrogen receptor antagonist 62 Raltegravir 62 Arranon 62 RhuDex ® 62 Panzem R NCD 62 mitoxantrone 62 carboplatin paclitaxel 62 alpha 2a 62 biliary tract cancer 62 clodronate 62 TREANDA 62 imatinib 62 Targeted Therapy 62 Pegintron 62 Vincristine 62 oral antiviral 62 CsA 62 TNF inhibitors 62 AEG# 62 CellCept 62 SCCHN 62 Peginterferon alfa 2b 62 regorafenib 62 DU #b 62 Ciclesonide 62 Raptiva ® 62 investigational monoclonal antibody 61 IMC A# 61 hormone LHRH antagonist 61 hypomethylating agents 61 Tipranavir 61 voriconazole 61 mTOR mammalian target 61 rFVIIa 61 TYGACIL 61 TNFα 61 Ceflatonin 61 Camptosar 61 Ozarelix 61 Celgene Revlimid 61 Peg IFN 61 panitumumab Vectibix 61 Teriflunomide 61 gastrointestinal stromal tumors 61 generation purine nucleoside 61 insulin sensitizers 61 Metastatic Renal Cell Carcinoma 61 relapsed MM 61 Zorbtive TM 61 lapatinib 61 secondary hyperparathyroidism 61 Cimzia certolizumab pegol 61 Castration Resistant Prostate Cancer 61 relapsed ovarian cancer 61 paclitaxel Taxol ® 61 Simulect 61 HER2 positive metastatic breast 61 Advanced Melanoma 61 Zoledronic Acid 61 interferon beta 1b 61 XYOTAX TM 61 etoposide 61 Survival Benefit 61 anti TNF 61 antibody MAb 61 taxanes 61 Novantrone 61 Yervoy 61 trans retinoic acid 61 TNF blocker 61 PEG SN# 61 Roche Pegasys 61 HuMax CD# 61 paclitaxel Taxol R 61 Cimzia ® 61 invasive candidiasis 61 Annamycin 61 chemotherapeutic agent 61 KRN# 61 Dacogen injection 61 meropenem 61 Telaprevir 61 Xelox 61 Rebif ® 61 Kinoid 61 Vascular Endothelial Growth 61 Cyclosporin 61 Rheumatoid Arthritis Patients 61 Autologous Stem Cell Transplantation 61 Ontak 61 Interferon alpha 61 Panitumumab 61 Octreotide 61 Improved Survival 61 HERCEPTIN 61 methylnaltrexone 61 palifermin 61 Androgen Deprivation Therapy 61 Interferon 61 colony stimulating factor 61 Zortress 61 Vectibix 61 Randomized Phase 61 ZACTIMA 61 pancreatic enzyme replacement 61 Montelukast 61 IFN alpha 61 ONTAK 61 Temodar ® 61 fludarabine cyclophosphamide 61 efavirenz EFV 61 familial amyloidotic polyneuropathy FAP 61 Is Well Tolerated 61 Improves Survival 61 immunosuppressive regimen 61 Investigational Compound 61 Genentech Herceptin 61 mesylate 61 MabThera rituximab 61 Vidaza R 61 Methylnaltrexone 61 Vimpat R 61 immunomodulator 61 Ceftaroline 61 Bisphosphonate 61 iniparib 61 pegylated interferons 61 Betaferon R 61 Perifosine 61 Darusentan 61 Bevacizumab Avastin 61 tenofovir Viread 61 refractory chronic myeloid 61 stage IIIB 61 Pregabalin 61 Sycrest 61 HRPC 61 Desmoteplase 61 Taxanes 61 Allogeneic 61 Colorectal Cancer Patients 61 humanized monoclonal antibody 61 Estrogen Receptor 61 REVLIMID ® 61 JAK inhibitor 61 Budesonide 61 ONCASPAR 61 Interferon Alfa 61 liposomal doxorubicin 61 Prolongs Survival 61 pimozide 61 chronic myeloid leukemia CML 61 reslizumab 61 thymalfasin 61 Neoral 61 imipenem 61 Blinatumomab 61 Chronic Hepatitis C 61 Oral Fingolimod 61 ARCALYST 61 Eraxis 61 bortezomib 61 Adefovir 61 cetuximab Erbitux 61 Trabectedin 61 VALSTAR 61 Panzem R 61 peginterferon 61 milatuzumab 61 Sustiva efavirenz 61 fostamatinib 61 Campath ® 61 Bleomycin 61 fondaparinux 61 oral proteasome inhibitor 61 Clevudine 61 Xeloda ® 61 Sipuleucel T 61 TELINTRA 61 Pivotal Study 61 Satraplatin 61 Aurora Kinase 61 Atrasentan 61 RezularTM 61 Imiquimod 61 Tamibarotene 61 Onconase 61 Cethromycin 61 antibody MT# 61 MGd 61 veltuzumab 61 Dabigatran etexilate 61 INTELENCE 61 Olaparib 61 PRT# 61 Gaucher Disease 61 Advanced Prostate Cancer 61 DMARDS 61 Erbitux cetuximab 61 Lamotrigine 61 pegylated interferon alfa 61 IRX 2 61 CD3 monoclonal antibody 61 TLR antagonist 61 epratuzumab 61 Cremophor 61 IFN beta 61 NXL# 61 Pegylated Liposomal Doxorubicin 61 RANK ligand 61 HuLuc# 61 CYT# potent vascular disrupting 61 FOLFOX6 61 PDE4 inhibitor 61 Pegylated interferon 61 Cytoxan 61 REVLIMID 61 Chronic Myeloid Leukemia CML 61 APTIVUS 61 immunotherapeutic agent 61 6 mercaptopurine 61 Efficacious 61 intravenously administered 61 Lamivudine 61 amrubicin 61 Pivotal Phase 61 cell lymphoma CTCL 61 erlotinib 61 APTIVUS R 61 Patients Treated With 61 metastatic malignant melanoma 61 pegylated 61 nilotinib Tasigna 61 panobinostat 61 elacytarabine 61 PEG IFN 61 polymerase inhibitor 61 Liposomal 61 SIR Spheres 61 IMA# 61 HoFH 61 metastatic castration resistant 61 daptomycin 61 docetaxel Taxotere R 61 pitavastatin 61 Panzem 61 huN# DM1 61 Myocet 61 Belatacept 60 systemic antifungal 60 PNP inhibitor 60 Abiraterone Acetate 60 letrozole Femara 60 chemoradiotherapy 60 Nitazoxanide 60 Lisofylline 60 Bucindolol 60 corticosteroid dexamethasone 60 direct thrombin inhibitors 60 G CSF 60 Abacavir 60 EGFR tyrosine kinase inhibitor 60 IFN α 60 interferon gamma 1b 60 Diabetic Neuropathic Pain 60 LHRH agonists 60 FOLFOX4 60 Tyrosine Kinase Inhibitor 60 Privigen 60 nucleoside reverse transcriptase inhibitor 60 Inhalation Solution 60 IL# PE#QQR 60 Mycamine 60 filgrastim 60 PROCRIT 60 vinca alkaloid 60 rhIL 7 60 antibody trastuzumab 60 Liprotamase 60 Radiofrequency Ablation RFA 60 MAb 60 Salmeterol 60 entecavir 60 Cancidas 60 Tesamorelin 60 BANZEL 60 Troxatyl 60 gefitinib 60 sipuleucel T 60 vWF 60 anti angiogenic agent 60 Aplidin 60 Protelos 60 Sunitinib 60 hypereosinophilic syndrome 60 idraparinux 60 Treated Patients 60 Arzerra ofatumumab 60 Relapsing Remitting Multiple Sclerosis 60 Zebinix 60 SNT MC# 60 Tarceva TM 60 DORIBAX 60 Neupogen ® 60 Interferon Beta 60 Vfend 60 administered subcutaneously 60 RoACTEMRA 60 histone deacetylase HDAC inhibitor 60 pegylated interferon alfa 2a 60 Elotuzumab 60 Metastatic Prostate Cancer 60 Chronic Sinusitis 60 glatiramer 60 CA4P 60 Erythropoietin 60 itraconazole 60 trastuzumab Herceptin R 60 Cell Lymphoma 60 Diabetic Nephropathy 60 YERVOY 60 Cimzia R 60 PROCHYMAL 60 Arzerra 60 STELARA TM 60 amifostine 60 PARP inhibitors 60 Platinol 60 aprepitant 60 MAGE A3 ASCI 60 baminercept 60 etanercept 60 Archexin 60 azoles 60 Atacand 60 Betaferon ® 60 VEGF receptor 60 Chronic Lymphocytic Leukemia CLL 60 Certolizumab 60 IMiDs 60 sorafenib 60 Non Hodgkin 60 Phase III Clinical Trial 60 Ixabepilone 60 imatinib mesylate Gleevec 60 cardiac toxicity 60 Novartis Afinitor 60 immunosuppressives 60 Inhibitor 60 HER2 Positive Breast Cancer 60 FUSILEV enhances 60 BAL# [002] 60 Tiuxetan 60 palonosetron 60 Halaven 60 DAPT 60 cytotoxic chemotherapy 60 leucovorin 60 REYATAZ R 60 immunosuppressive therapies 60 Neuvenge 60 fingolimod 60 rNAPc2 60 Leucovorin 60 plus prednisone 60 Dutasteride 60 Candesartan 60 CCR5 antagonist 60 Rilutek 60 Abiraterone acetate 60 Tanespimycin 60 ATL# [001] 60 LymphoStat B belimumab 60 Allovectin 7 60 follicular lymphoma FL 60 antiangiogenic therapy 60 Phase 2b Clinical Trial 60 interleukin IL -# 60 Akt activation 60 cisplatin chemotherapy 60 dexamethasone Decadron 60 Anti Tumor Activity 60 angiotensin converting enzyme inhibitors 60 GnRH agonist 60 Rheumatoid Arthritis RA 60 Carvedilol 60 metastatic RCC 60 tyrosine kinase inhibitors 60 octreotide 60 HSP# inhibitor 60 targeted antifolate 60 Idiopathic Pulmonary Fibrosis 60 Hepatitis C Patients 60 Teriparatide 60 CIMZIA 60 Romidepsin 60 evaluating tivozanib 60 VIDAZA 60 Phase 2b Study 60 BARACLUDE ® 60 Gemzar gemcitabine 60 ACTEMRA TM 60 NDA Submission 60 Safinamide 60 cidofovir 60 zalutumumab 60 imatinib therapy 60 amikacin 60 HQK 60 natalizumab 60 Metastatic Melanoma 60 Bayer Nexavar 60 tyrosine kinase inhibitors TKIs 60 TBC# 60 mertansine 60 Hepatocellular Carcinoma 60 Glioblastoma Multiforme 60 Tyrosine Kinase Inhibitors 60 Study Evaluating 60 PROCRIT ® 60 TAXOL R 60 Pegasys peginterferon alfa 2a 60 OncoVEX GM CSF 60 IgG1 monoclonal antibody 60 Raptiva R 60 HDACi 60 peginterferon alfa 2a Pegasys 60 5FU 60 Platinol ® cisplatin 60 Acute Myeloid Leukemia AML 60 peginterferon alfa 60 TACE 60 ZD# [001] 60 REVLIMID lenalidomide 60 ALVESCO ® 60 allogeneic stem cell 60 ABRAXANE ® 60 5-FU/LV 60 candesartan 60 ISENTRESS 60 capecitabine Xeloda 60 estramustine 60 EFAPROXYN 60 Apaziquone 60 bexarotene 60 Oral Formulation 60 Azedra 60 rituximab refractory 60 Exelixis XL# 60 relapsed leukemia 60 RAPAFLO 60 Goserelin 60 Levodopa 60 Caelyx 60 Ilaris 60 Cilostazol 60 candesartan cilexetil 60 Patients Receiving 60 IMiDs ® compound 60 molecularly targeted 60 malignant pleural mesothelioma 60 ACTEMRA 60 abiraterone acetate 60 Nuvion 60 registrational trial 60 R sorafenib tablets 60 ofatumumab HuMax CD#

Back to home page